| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Rhodes Jason P is a Director at REPL with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 77 sells.
Estimated insider holdings value: $5.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | DYN Dyne Therapeutics, Inc. | Director | Sell | 227,337 | $18.38 | $4,178,516.06 | -1.5% | - | - | |
| Apr 27, 2026 | DYN Dyne Therapeutics, Inc. | Director | Sell | 384,549 | $18.47 | $7,101,119.51 | -1.6% | - | - | |
| Apr 22, 2026 | DYN Dyne Therapeutics, Inc. | Director | Sell | 834,302 | $19.75 | $16,477,387.75 | -2.4% | - | - | |
| Nov 14, 2024 | DYN Dyne Therapeutics, Inc. | Director | Sell | 782 | $33.10 | $25,884.20 | - | -54.1% | -38.0% | |
| Mar 1, 2024 | DYN Dyne Therapeutics, Inc. | Director | Sell | 46,534 | $30.05 | $1,398,346.70 | -2.0% | +7.1% | -53.3% | |
| Feb 28, 2024 | DYN Dyne Therapeutics, Inc. | Director | Sell | 534,857 | $24.24 | $12,964,557.29 | -1.3% | +20.1% | -47.3% | |
| Feb 23, 2024 | DYN Dyne Therapeutics, Inc. | Director | Sell | 500,789 | $22.64 | $11,339,780.44 | -1.7% | +37.1% | -38.5% | |
| Feb 20, 2024 | DYN Dyne Therapeutics, Inc. | Director | Sell | 510,152 | $23.26 | $11,867,292.26 | -1.4% | +55.6% | -39.2% | |
| Dec 12, 2022 | DYN Dyne Therapeutics, Inc. | Director | Buy | 934,581 | $10.70 | $10,000,016.70 | New | +13.1% | -5.9% | |
| Sep 29, 2021 | GBIO Generation Bio Co. | Director | Sell | 81,088 | $25.40 | $2,059,519.16 | -62.8% | -67.6% | -79.0% |